Fluorescence optical imaging in patients with active rheumatoid arthritis: a comparison with ultrasound and an association with biomarkers

References

• Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631–7.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 2016;75:3–15.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 2017;76:960–77.
   PubMed Web of Science ®Google Scholar
• D’Agostino MA, Boers M, Wakefield RJ, Emery P, Conaghan PG. Is it time to revisit the role of ultrasound in rheumatoid arthritis management? Ann Rheum Dis 2017;76:7–8.
   PubMed Web of Science ®Google Scholar
• Colebatch AN, Edwards CJ, Østergaard M, van der Heijde D, Balint PV, D’Agostino MA, et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis 2013;72:804–14.
   PubMed Web of Science ®Google Scholar
• Werner SG, Langer HE, Ohrndorf S, Bahner M, Schott P, Schwenke C, et al. Inflammation assessment in patients with arthritis using a novel in vivo fluorescence optical imaging technology. Ann Rheum Dis 2012;71:504–10.
   PubMed Web of Science ®Google Scholar
• Werner SG, Langer HE, Schott P, Bahner M, Schwenke C, Lind-Albrecht G, et al. Indocyanine green-enhanced fluorescence optical imaging in patients with early and very early arthritis: a comparative study with magnetic resonance imaging. Arthritis Rheum 2013;65:3036–44.
   PubMed Web of Science ®Google Scholar
• Schäfer VS, Hartung W, Hoffstetter P, Berger J, Stroszczynski C, Müller M, et al. Quantitative assessment of synovitis in patients with rheumatoid arthritis using fluorescence optical imaging. Arthritis Res Ther 2013;15:R124.
   PubMed Web of Science ®Google Scholar
• Meier R, Thuermel K, Noël PB, Moog P, Sievert M, Ahari C, et al. Synovitis in patients with early inflammatory arthritis monitored with quantitative analysis of dynamic contrast-enhanced optical imaging and MR imaging. Radiology 2014;270:176–85.
   PubMed Web of Science ®Google Scholar
• Beck MC, Glimm AM, Ohrndorf S, Minden K, Trauzeddel R, Werner SG, et al. Fluorescence optical imaging in pediatric patients with inflammatory and non-inflammatory joint diseases: a comparative study with ultrasonography. Arthritis Res Ther 2017;19:233.
   PubMed Web of Science ®Google Scholar
• Thuermel K, Neumann J, Jungmann PM, Schäffeler C, Waldt S, Heinze A, et al. Fluorescence optical imaging and 3T-MRI for detection of synovitis in patients with rheumatoid arthritis in comparison to a composite standard of reference. Eur J Radiol 2017;90:6–13.
   PubMed Web of Science ®Google Scholar
• Boddington S, Sutton EJ, Jones E, Purcell DD, Henning TD, Tavri S, et al. Improved fluorescence of indocyanine green in vitro and in vivo after simple cooling procedures. Contrast Media Mol Imaging 2008;3:191–7.
   PubMed Web of Science ®Google Scholar
• Eisenblätter M, Höltke C, Persigehl T, Bremer C. Optical techniques for the molecular imaging of angiogenesis. Eur J Nucl Med Mol Imaging 2010;37(Suppl 1):S127–S37.
   PubMed Web of Science ®Google Scholar
• Fischer T, Gemeinhardt I, Wagner S, Stieglitz DV, Schnorr J, Hermann KG, et al. Assessment of unspecific near-infrared dyes in laser-induced fluorescence imaging of experimental arthritis. Acad Radiol 2006;13:4–13.
   PubMed Web of Science ®Google Scholar
• Meier R, Krug C, Golovko D, Boddington S, Piontek G, Rudelius M, et al. Indocyanine green-enhanced imaging of antigen-induced arthritis with an integrated optical imaging/radiography system. Arthritis Rheum 2010;62:2322–7.
   PubMed Web of Science ®Google Scholar
• Kisten Y, Györi N, Af Klint E, Rezaei H, Levitsky A, Karlsson A, et al. Detection of clinically manifest and silent synovitis in the hands and wrists by fluorescence optical imaging. RMD Open 2015;1:e000106.
   PubMed Web of Science ®Google Scholar
• Pap T, Distler O. Linking angiogenesis to bone destruction in arthritis. Arthritis Rheum 2005;52:1346–8.
   PubMed Web of Science ®Google Scholar
• Kawashiri SY, Kawakami A, Iwamoto N, Fujikawa K, Satoh K, Tamai M, et al. The power Doppler ultrasonography score from 24 synovial sites or 6 simplified synovial sites, including the metacarpophalangeal joints, reflects the clinical disease activity and level of serum biomarkers in patients with rheumatoid arthritis. Rheumatology (Oxford) 2011;50:962–5.
   PubMed Web of Science ®Google Scholar
• Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 2008;58:2958–67.
   PubMed Web of Science ®Google Scholar
• Fujimori M, Kamishima T, Kato M, Seno Y, Sutherland K, Sugimori H, et al. Composite assessment of power Doppler ultrasonography and MRI in rheumatoid arthritis: a pilot study of predictive value in radiographic progression after one year. Br J Radiol 2018;91:20170748.
   PubMed Web of Science ®Google Scholar
• Kawashiri SY, Nishino A, Shimizu T, Umeda M, Fukui S, Nakashima Y, et al. Ultrasound disease activity of bilateral wrist and finger joints at three months reflects the clinical response at six months of patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs. Mod Rheumatol 2017;27:252–6.
   PubMed Web of Science ®Google Scholar
• Nishino A, Kawashiri SY, Koga T, Iwamoto N, Ichinose K, Tamai M, et al. Ultrasonographic efficacy of biologic and targeted synthetic disease-modifying antirheumatic drug therapy in rheumatoid arthritis from a multicenter rheumatoid arthritis ultrasound prospective cohort in Japan. Arthritis Care Res (Hoboken) 2018;70:1719–26.
   PubMed Web of Science ®Google Scholar
• Taylor PC. VEGF and imaging of vessels in rheumatoid arthritis. Arthritis Res 2002;4(Suppl 3):S99–S107.
   PubMedGoogle Scholar
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580–8 and Arthritis Rheum 2010;62:2569–81.
   PubMed Web of Science ®Google Scholar
• Torp-Pedersen ST, Terslev L. Settings and artefacts relevant in colour/power Doppler ultrasound in rheumatology. Ann Rheum Dis 2008;67:143–9.
   PubMed Web of Science ®Google Scholar
• D’Agostino MA, Terslev L, Aegerter P, Backhaus M, Balint P, Bruyn GA, et al. Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 1: Definition and development of a standardised, consensus-based scoring system. RMD Open 2017;3:e000428.
   PubMed Web of Science ®Google Scholar
• Kawashiri SY, Fujikawa K, Nishino A, Takatani A, Shimizu T, Umeda M, et al. Combination of ultrasound power Doppler-verified synovitis and seropositivity accurately identifies patients with early-stage rheumatoid arthritis. Int J Rheum Dis 2019;22:842–51.
   PubMed Web of Science ®Google Scholar
• Gutierrez M, Filippucci E, Salaffi F, Di Geso L, Grassi W. Differential diagnosis between rheumatoid arthritis and psoriatic arthritis: the value of ultrasound findings at metacarpophalangeal joints level. Ann Rheum Dis 2011;70:1111–14.
   PubMed Web of Science ®Google Scholar
• Glimm AM, Werner SG, Burmester GR, Backhaus M, Ohrndorf S. Analysis of distribution and severity of inflammation in patients with osteoarthritis compared to rheumatoid arthritis by ICG-enhanced fluorescence optical imaging and musculoskeletal ultrasound: a pilot study. Ann Rheum Dis 2016;75:566–70.
   PubMed Web of Science ®Google Scholar
• Glimm AM, Sprenger LI, Haugen IK, Mansmann U, Hermann S, Häupl T, et al. Fluorescence optical imaging for treatment monitoring in patients with early and active rheumatoid arthritis in a 1-year follow-up period. Arthritis Res Ther 2019;21:209.
   PubMedGoogle Scholar
• van Onna M, Ten Cate DF, Tsoi KL, Meier AJ, Jacobs JW, Westgeest AA, et al. Assessment of disease activity in patients with rheumatoid arthritis using optical spectral transmission measurements, a non-invasive imaging technique. Ann Rheum Dis 2016;75:511–18.
   PubMed Web of Science ®Google Scholar
• Besselink NJ, van der Meijde P, Rensen WHJ, Meijer PBL, Marijnissen ACA, van Laar JM, et al. Optical spectral transmission to assess inflammation in hand and wrist joints of rheumatoid arthritis patients. Rheumatology (Oxford) 2018;57:865–72.
   PubMed Web of Science ®Google Scholar